Obsessive-compulsive disorder and Atrioventricular block second degree

Summary:

Atrioventricular block second degree is found among people with Obsessive-compulsive disorder, especially for people who are male, 20-29 old.

The study analyzes which people have Atrioventricular block second degree with Obsessive-compulsive disorder. It is created by eHealthMe based on reports of 13 people who have Obsessive-compulsive disorder from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Obsessive-compulsive disorder?

Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;) is found to be associated with 677 drugs and 1,312 conditions by eHealthMe. Check the latest studies of Obsessive-compulsive disorder.

What is Atrioventricular block second degree?

Atrioventricular block second degree (heart block second degree) is found to be associated with 374 drugs and 819 conditions by eHealthMe. Check the latest studies of Atrioventricular block second degree.



On Aug, 07, 2026

13 people who have Obsessive-Compulsive Disorder and Atrioventricular Block Second Degree are studied.

Would you have Atrioventricular block second degree when you have Obsessive-compulsive disorder?

Gender of people who have Obsessive-Compulsive Disorder and experienced Atrioventricular Block Second Degree *:

  • female: 15.38 %
  • male: 84.62 %

Age of people who have Obsessive-Compulsive Disorder and experienced Atrioventricular Block Second Degree *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 8.33 %
  • 20-29: 75.0 %
  • 30-39: 16.67 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. Stress And Anxiety: 2 people, 15.38%
  2. Hallucinations (sensations that appear real but are created by your mind): 2 people, 15.38%
  3. Acne (skin problems that cause pimples): 2 people, 15.38%

Common drugs taken by these people *:

  1. Risperdal: 8 people, 61.54%
  2. Concerta: 8 people, 61.54%
  3. Abilify: 8 people, 61.54%
  4. Sertraline: 6 people, 46.15%
  5. Fluoxetine: 4 people, 30.77%
  6. Lexapro: 2 people, 15.38%
  7. Invega: 2 people, 15.38%
  8. Celexa: 2 people, 15.38%
  9. Ativan: 2 people, 15.38%

Common symptoms for these people *:

  1. Cardiac Arrest: 9 people, 69.23%
  2. Maternal Exposure During Pregnancy (use of substance during pregnancy): 2 people, 15.38%
  3. Hypotension (abnormally low blood pressure): 2 people, 15.38%
  4. Heart Palpitations (feelings or sensations that your heart is pounding or racing): 2 people, 15.38%
  5. Fatigue (feeling of tiredness): 2 people, 15.38%
  6. Bradycardia (abnormally slow heart action): 2 people, 15.38%
  7. Atrioventricular Dissociation (av block): 2 people, 15.38%
  8. Atrioventricular Block Complete (heart block complete): 2 people, 15.38%
  9. Sinus Tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node): 1 person, 7.69%
  10. Arrhythmias (irregular heartbeat): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Atrioventricular block second degree?

- Check whether Atrioventricular block second degree is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Atrioventricular block second degree:

All the conditions that are associated with Atrioventricular block second degree:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Atrioventricular block second degree and Obsessive-compulsive disorder, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: